Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma
Titel:
Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma
Auteur:
Kim, H.R. Kang, H.N. Shim, H.S. Kim, E.Y. Kim, J. Kim, D.J. Lee, J.G. Lee, C.Y. Hong, M.H. Kim, S.-M. Kim, H. Pyo, K.-H. Yun, M.R. Park, H.J. Han, J.Y. Youn, H.A. Ahn, M.-J. Paik, S. Kim, T.-M. Cho, B.C.